REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 24 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,237,000 | -89.9% | 1,146,000 | -92.4% | 0.11% | -90.4% |
| Q2 2022 | $12,253,000 | -19.7% | 15,058,000 | -7.3% | 1.16% | -13.5% |
| Q1 2022 | $15,254,000 | -16.8% | 16,238,000 | +2.1% | 1.34% | -16.1% |
| Q3 2021 | $18,336,000 | -1.2% | 15,910,000 | 0.0% | 1.60% | -3.7% |
| Q2 2021 | $18,551,000 | +5.7% | 15,910,000 | +1.7% | 1.66% | -19.7% |
| Q1 2021 | $17,558,000 | – | 15,650,000 | – | 2.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |